NYSE:ABT - Post Discussion
Post by
whytestocks on Jan 24, 2024 7:30pm
Abbott Laboratories Surpasses Q4 Sales Expectations, Despite
Just In: $ABT Abbott Laboratories Surpasses Q4 Sales Expectations, Despite Dip In COVID-19 Testing Demand | BenzingaAbbott Laboratories (NYSE:ABT) posted higher sales of $10.24 billion in the fourth quarter, despite continued soft demand for the company̵...
ABT - Abbott Laboratories Surpasses Q4 Sales Expectations, Despite Dip In COVID-19 Testing Demand | Benzinga
Be the first to comment on this post